参考文献
[1] Bayers S, Shulman ST, Paller AS. Kawasaki disease: part Ⅱ. complications and treatment[J]. J Am Acad Dermatol, 2013, 69(4):513. DOI: 10.1016/j.jaad.2013.06.040.
[2] Oharaseki T, Yokouchi Y, Yamada H, et al. The role of TNF-α in a murine model of Kawasaki disease arteritis induced with a Candida albicans cell wall polysaccharide[J]. Mod Rheumatol, 2014, 24(1):120-128. DOI: 10.3109/14397595.2013.854061.
[3] Lee Y, Schulte DJ, Shimada K, et al. Interleukin-1β is crucial for the induction of coronary artery inflammation in a mouse model of Kawasaki disease[J]. Circulation, 2012, 125(12):1542-1550. DOI: 10.1161/CIRCULATIONAHA.111.072769.
[4] Checchia PA, Pahl E, Shaddy RE, et al. Cardiac transplantation for Kawasaki disease[J]. Pediatrics, 1997,100(4):695-699.
[5] Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association[J]. Circulation, 2004, 110(17):2747-2771. DOI: 10.1161/01.CIR.0000145143.19711.78.